The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC

July 27, 2010 4:34 am | by Bio-Medicine.Org | News | Comments

MUNDELEIN, Ill. , July 27 /- Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced plans to debut its expanded cell image analysis portfolio during this year's American Association of Clinical Chemistry's (AACC)...


Preventing heart problems while keeping a cool head

July 27, 2010 4:33 am | by EurekAlert | News | Comments

(Max-Planck-Gesellschaft) Max Planck researchers explain the cause of the flushing effect arising from cholesterol treatment with nicotinic acid.


Millennium Laboratories, Inc. Urges Medicare to Reconsider the 2010 Physician Reimbursement for Point-of-Care Urine Drug Screen Devices

July 27, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , July 27 /- Millennium Laboratories, Inc., a national, research-based medication monitoring company specifically focused on clinicians who treat chronic pain, strongly advocated for an increase in physician reimbursement for point-of-care urine drug screening at the Annual...


Former CEO drops bid for Northstar Healthcare due to change in finances

July 26, 2010 2:45 pm | by The Associated Press | News | Comments

A company headed by a former chief executive has dropped it takeover offer for Northstar Healthcare Inc. (TSX:NHC) due to a "material adverse change" in the ambulatory surgery provider's financial condition.Donald Kramer had said he would form a new company, Canada Healthcare Acquisition Inc.,...

IPC 2Q net income rises 32 percent on patients

July 26, 2010 1:45 pm | by The Associated Press | News | Comments

IPC The Hospitalist Company Inc., a provider of in-hospital medical services, said Monday its second-quarter net income rose 32 percent on a boost in patients.Net income in the quarter rose to $5.4 million, or 33 cents per share, compared with $4.1 million, or 25 cents per share, a year ago....

Doctors don't 'get' their patients

July 26, 2010 12:40 pm | by EurekAlert | News | Comments

(Springer) US physicians are often poor judges of their patients' health beliefs, according to a new study. However, physicians' understanding is better the more patients are involved by asking questions, expressing concerns, and stating their beliefs and preferences for care....


Luxottica reports 2Q improvement on better sales

July 26, 2010 11:45 am | by The Associated Press | News | Comments

Luxury eyewear company Luxottica Group SpA on Monday reported that its net income rose 30 percent in the second quarter as sales improved.The Italian company recorded income of 150.1 million euros ($195 million), or 33 euro cents (42 cents) per share, for the quarter. That's up from 115.3...

American Medical Response adds chief doctor

July 26, 2010 11:45 am | by The Associated Press | News | Comments

GREENWOOD VILLAGE, Colo. (AP) — A unit of Emergency Medical Services Corp. said on Monday that it has named Dr. Edward Racht to the new position of Chief Medical Officer.The company's American Medical Response unit runs ambulance services in 38 states and Washington D.C. Racht has been an emergency...


Boston Scientific launches new stent system

July 26, 2010 10:45 am | by The Associated Press | News | Comments

Boston Scientific Corp. said Monday it started selling its Neuroform EZ Stent System, aimed at treating brain aneurysms.The company said the system is its fourth-generation intracranial aneurysm stent system. Boston Scientific said it will demonstrate its Neuroform EZ Stent System at the 7th...

Seeing the forest and the trees reveals heart problems

July 26, 2010 10:38 am | by EurekAlert | News | Comments

(Inderscience Publishers) A statistical analysis of publicly available heart rate data using three classification tools -- Random Forests, Logistic Model Tree and Neural Network -- could lead to a rapid and precise way to diagnose heart problems, according to research in the...


Seaside advances autism drug

July 26, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Seaside Therapeutics Inc. has announced positive results from a Phase 2 trial for a drug candidate to treat fragile X, the most common form of autism.

Nanoviricides files to raise funds

July 26, 2010 10:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Nanoviricides Inc., a Connecticut developer of drugs to fight challenging infectious diseases, has filed federal documents stating it is seeking to raise an indeterminate amount of funding in what appears to be a private investment in a public entity (PIPE).

Home Medical Equipment Providers Recognize Americans with Disabilities Act 20th Anniversary, Vow to Fight for Greater Access to Care

July 26, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

ARLINGTON, Va. , July 26 /PRNewswire-USNewswire/ -- Providers of home medical equipment and services, such as wheelchairs, oxygen therapy, and diabetic supplies, are recognizing the importance of the 20th anniversary of the Americans with Disabilities Act (ADA) today. Home medical...


Yale cell researchers win $2.5M grants

July 26, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Two Yale University scientists working on cell biology have been named as recipients of the 2010 Pioneer Award from the National Institutes of Health, with each recipient receiving a $2.5 million grant and laboratory support for five years.


Why Do We Like What We Like?

July 26, 2010 9:36 am | Podcasts | Comments

Why do we enjoy things like bitter foods and horror films? And are we the only species that likes art? Paul Bloom, professor of psychology at Yale University and author of How Pleasure Works, explains our penchant for art and why we find some unpleasant things so enjoyable.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.